<DOC>
	<DOC>NCT00189241</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term sustained clearance rate of superficial basal cell carcinoma during a 5 year period following treatment with imiquimod</brief_summary>
	<brief_title>A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Basal Cell</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Have one superficial BCC primary tumour Minimum tumour area of 0.5cm2, maximum diameter of 2.0cm. If female and of child bearing potential, negative pregnancy test and willing to use medically acceptable method of contraception. Evidence of clinically significant, unstable medical conditions. Evidence of Gorlin syndrome, metastatic tumour or tumour with high probability of metastatic spread, have or have had within last 5 years other malignant cancers of the skin at target tumour site. Have received defined treatments in tumour site or surrounding area. Any dermatological disease in the target tumour site or surrounding area. Have had a systemic bacterial or viral infection within 2 weeks prior to study initiation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Aldara</keyword>
	<keyword>Superficial Basal Cell Carcinoma</keyword>
	<keyword>Long-Term Study</keyword>
</DOC>